MedPath

CINQAERO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

CINQAERO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1161125001

Prescription Type

Uso Hospitalario

Authorization Date

Oct 20, 2016

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1161125001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RESLIZUMABActive
Quantity: 10 mg
Name: RESLIZUMAB

ATC CLASSIFICATION (3)

R03D
R03DX
R03DX08

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.